{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 448239916
| IUPAC_name = 3-methyl-4-morpholin-4-yl-2,2-diphenyl-1-pyrrolidin-1-yl-butan-1-one
| image = Racemoramide.svg

<!--Clinical data-->
| tradename = 
| pregnancy_category = 
| legal_CA = Schedule I
| legal_US = Schedule I
| legal_DE = Anlage II
| routes_of_administration = 

<!--Pharmacokinetic data-->
| bioavailability = 
| metabolism = 
| excretion = 

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 545-59-5
| ATC_prefix = none
| ATC_suffix = 
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = L3J8QT828G
| PubChem = 9648
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 9269
| smiles = O=C(N1CCCC1)C(c2ccccc2)(c3ccccc3)C(C)CN4CCOCC4
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C25H32N2O2/c1-21(20-26-16-18-29-19-17-26)25(22-10-4-2-5-11-22,23-12-6-3-7-13-23)24(28)27-14-8-9-15-27/h2-7,10-13,21H,8-9,14-20H2,1H3
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = INUNXTSAACVKJS-UHFFFAOYSA-N

<!--Chemical data-->
| C=25 | H=32 | N=2 | O=2 
| molecular_weight = 392.534 g/mol
}}

'''Racemoramide''' ([[International Nonproprietary Name|INN]], [[British Approved Name|BAN]]), or simply '''moramide''', is an [[opioid]] [[analgesic]] and a [[racemic mixture]] of the substances [[dextromoramide]] (the active component) and [[levomoramide]] (which is inactive), two [[enantiomer]]s of a [[chirality (chemistry)|chiral molecule]].<ref name="GanellinTriggle1997">{{cite book | author1 = C. R Ganellin | author2 = D. J Triggle | author3 = F.. Macdonald | title = Dictionary of pharmacological agents | url = https://books.google.com/books?id=A0THacd46ZsC&pg=PA1375 | accessdate = 29 November 2011 | year = 1997 | publisher = CRC Press | isbn = 978-0-412-46630-4 | page = 1375}}</ref>

Racemoramide is itself controlled; in the United States it is under Schedule I as a Narcotic with an ACSCN of 9645 and a zero annual aggregate manufacturing quota as of 2014.<ref>http://www.deadiversion.usdoj.gov/quotas/conv_factor/index.html</ref> Its salts are the bitartrate (free base conversion ratio 0.723) and dihydrochloride (0.843)

Moramide intermediate is listed separately as a Schedule II Narcotic controlled substance (ACSCN 9802), also with a zero quota.<ref>http://www.deadiversion.usdoj.gov/quotas/conv_factor/index.html</ref>

== References ==
{{Reflist}}


{{Opioidergics}}

[[Category:Analgesics]]
[[Category:Morpholines]]
[[Category:Opioids]]
[[Category:Propionamides]]
[[Category:Pyrrolidines]]


{{analgesic-stub}}